https://www.selleckchem.com/pr....oducts/epacadostat-i
Patients with small renal masses (SRM) can be exposed to overdiagnosis and overtreatment. As such, active surveillance (AS) is recommended by all Guidelines for selected patients. However, it remains underutilized. One key reason is the lack of consensus on the factors prompting delayed intervention (DI). Herein we provide an updated overview of the triggers for DI in patients with SRMs initially undergoing AS. A systematic review of the English-language literature was performed according to the PRISMA statement recommend
Like
Comment
Share
